Oncothyreon Announces Presentations at Upcoming Investment Conferences in November 2012
SEATTLE, Nov. 7, 2012 /PRNewswire/ – Oncothyreon Inc. (Nasdaq: ONTY) announced
today that management will be presenting at the following upcoming
investment conferences in November.
Lazard Capital Markets 9th Annual Healthcare Conference
Wednesday, November 14, 2012, at 3:00 p.m. Eastern time in New York, NY
24(th) Annual Piper Jaffray Healthcare Conference
Tuesday, November 27, 2012, at 3 p.m. Eastern time in New York, NY
A live and archived webcast of each presentation will be accessible by
visiting the Oncothyreon website www.oncothyreon.com under the “News & Events” section.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon’s goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.